Billionaire Joseph Edelman's Top 10 Long-Term Stock Picks
Joseph Edelman is a renowned figure in the investment world, recognized for his expertise in biotechnology and healthcare investing.
Verona Pharma Plc (VRNA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Perceptive Advisors Joseph Edelman | 6,392,106 | $296,849,403 | +2% | 8.18% |
| 2. | Maverick Capital Lee Ainslie | 3,128,516 | $145,288,283 | -26% | 2.61% |
| 3. | Vivo Capital Albert Cha And Frank Kung | 2,283,975 | $106,067,799 | -36% | 11.88% |
| 4. | RA Capital Management Peter Kolchinsky | 1,766,830 | $82,051,585 | -65% | 1.09% |
| 5. | Hood River Capital Management David Swank | 1,485,256 | $68,975,289 | 1.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.44 | 20,000 | Director | 940,003 | 2024-11-18 | Filing | |
| $4.80 | 39,360 | Director | 920,003 | 2024-11-06 | Filing | |
| $4.74 | 41,880 | Director | 41,880 | 2024-11-06 | Filing | |
| $2.87 | 36,000 | Director | 880,643 | 2024-08-12 | Filing | |
| $1.84 | 33,736 | Director | 144,800 | 2023-11-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.01 | 162,800 | Officer, Director | 14,204,752 | 2024-12-06 | Filing | |
| $5.01 | 640,264 | Officer, Director | 14,367,552 | 2024-12-05 | Filing | |
| $5.00 | 67,608 | Officer, Director | 15,007,816 | 2024-12-04 | Filing | |
| $5.01 | 183,728 | Officer | 13,293,736 | 2024-12-06 | Filing | |
| $5.01 | 640,048 | Officer | 13,477,464 | 2024-12-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,584,753 | $259,355,930 | 14.63% | |
| 2. | 3,383,950 | $157,150,638 | 6.52% | |
| 3. | 3,132,127 | $145,463,228 | 2.64% | |
| 4. | 3,025,241 | $140,492,194 | 0.02% | |
| 5. | 1,902,026 | $88,330,087 | 1.68% |
News See All
Verona Pharma plc (NASDAQ:VRNA) Q3 2024 Earnings Call Transcript
Operator: Good morning, everyone, and welcome to Verona Pharma's Third Quarter 2024 Financial Results and Operating Highlights Conference Call.
Verona Pharma plc (NASDAQ:VRNA) Q2 2024 Earnings Call Transcript
Operator: Welcome to Verona Pharma’s Second Quarter 2024 Financial Results and Operating Highlights Conference Call. At this time, all participants are in a listen-only mode.
Top 10 Holdings of Caligan Partners
Founded in 2017, Caligan Partners is one of the most significant specialty hedge funds.
Verona Pharma plc (NASDAQ:VRNA) Q1 2024 Earnings Call Transcript
Operator: Hello, and welcome to Verona Pharma's First Quarter 2024 Financial Results and Operating Highlights Conference Call. At this time, all participants are in a listen-only mode.
Verona Pharma plc (NASDAQ:VRNA) Q4 2023 Earnings Call Transcript
Verona Pharma plc beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.23.
11 Best Undervalued UK Stocks To Buy Now
In this piece, we will take a look at the 11 best undervalued U.K. stocks to buy now.
Verona Pharma plc (NASDAQ:VRNA) Q3 2023 Earnings Call Transcript
Operator: Welcome to Verona Pharma's Third Quarter 2023 Financial Results and Operating Highlights Conference Call. At this time, all participants are in a listen-only mode.
12 Best High Risk High Reward Stocks To Buy Now
In this piece, we will take a look at the 12 best high risk high reward stocks to buy now.
Verona Pharma plc (NASDAQ:VRNA) Q2 2023 Earnings Call Transcript
Operator: Welcome to Verona Pharma Second Quarter 2023 Financial Results and Operating Highlights Conference Call. At this time all participants are in listen-only mode.
Billionaire Hedge Funds
